Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial von Frank, Samuel, Testa, Claudia M, Stamler, David, Kayson, Elise, Davis, Charles, Edmondson, Mary C, Kinel, Shari, Leavitt, Blair, Oakes, David, O’Neill, Christine, Vaughan, Christina, Goldstein, Jody, Herzog, Margaret, Snively, Victoria, Whaley, Jacquelyn, Wong, Cynthia, Suter, Greg, Jankovic, Joseph, Jimenez-Shahed, Joohi, Hunter, Christine, Claassen, Daniel O, Roman, Olivia C, Sung, Victor, Smith, Jenna, Janicki, Sarah, Clouse, Ronda, Saint-Hilaire, Marie, Hohler, Anna, Turpin, Denyse, James, Raymond C, Rodriguez, Ramon, Rizer, Kyle, Anderson, Karen E, Heller, Hope, Carlson, Alexis, Criswell, Susan, Racette, Brad A, Revilla, Fredy J, Nucifora, Frederick, Margolis, Russell L, Ong, MaryJane, Mendis, Tilak, Mendis, Neila, Singer, Carlos, Quesada, Monica, Paulsen, Jane S, Brashers-Krug, Thomas, Miller, Amanda, Kerr, Jane, Dubinsky, Richard M, Gray, Carolyn, Factor, Stewart A, Sperin, Elaine, Molho, Eric, Eglow, Mary, Evans, Sharon, Kumar, Rajeev, Reeves, Christina, Samii, Ali, Chouinard, Sylvain, Beland, Monica, Scott, Burton L, Hickey, Patrick T, Esmail, Sherali, Fung, Wai Lun Alan, Gibbons, Clare, Qi, Lina, Colcher, Amy, Hackmyer, Cory, McGarry, Andrew, Klos, Kevin, Gudesblatt, Mark, Fafard, Lori, Graffitti, Laura, Schneider, Daniel P, Dhall, Rohit, Wojcieszek, Joanne M, LaFaver, Kathrin, Duker, Andrew, Neefus, Erin, Wilson-Perez, Hilary, Shprecher, David, Wall, Paola, Blindauer, Karen A, Wheeler, Lynn, Boyd, James T, Houston, Emily, Farbman, Eric S, Agarwal, Pinky, Eberly, Shirley W, Watts, Arthur, Tariot, Pierre N, Feigin, Andrew, Evans, Scott, Beck, Chris, Orme, Constance, Edicola, Jon, Christopher, Emily

Volltext

Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial von Simuni, Tanya, Fiske, Brian, Merchant, Kalpana, Coffey, Christopher S, Klingner, Elizabeth, Caspell-Garcia, Chelsea, Lafontant, David-Erick, Matthews, Helen, Wyse, Richard K, Brundin, Patrik, Simon, David K, Schwarzschild, Michael, Weiner, David, Adams, Jamie, Venuto, Charles, Dawson, Ted M, Baker, Liana, Kostrzebski, Melissa, Ward, Tina, Rafaloff, Gary

Volltext

Neural basis for impaired time reproduction in Parkinson's disease: An fMRI study von ELSINGER, CATHERINE L., RAO, STEPHEN M., ZIMBELMAN, JANICE L., REYNOLDS, NORMAN C., BLINDAUER, KAREN A., HOFFMANN, RAYMOND G.

Volltext

Relationship of Mediterranean Diet and Caloric Intake to Phenoconversion in Huntington Disease von Marder, Karen, Gu, Yian, Eberly, Shirley, Tanner, Caroline M, Scarmeas, Nikolaos, Oakes, David, Shoulson, Ira

Volltext

Dietary intake in adults at risk for Huntington disease: Analysis of PHAROS Research Participants von MARDER, K, ZHAO, H, EBERLY, S, TANNER, C. M, OAKES, D, SHOULSON, I

Volltext

Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease von Schwid, Steven R., Bausch, Janice, Oakes, David, Schuchter, Lynn, Tanner, Caroline, Forrest, Misser, Lang, Anthony E., Shoulson, Ira

Volltext

Transtelephonic Home Blood Pressure to Assess the Monoamine Oxidase-B Inhibitor Rasagiline in Parkinson Disease von WHITE, William B, SALZMAN, Phyllis, SCHWID, Steven R

Volltext

Randomized placebo- controlled study of the nicotinic agonist SIB-1508Y in Parkinson disease von Parkinson Study Group, The Parkinson Study Group

Volltext

Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm von Krouwer, HG, Kim, TA, Rand, SD, Prost, RW, Haughton, VM, Ho, KC, Jaradeh, SS, Meyer, GA, Blindauer, KA, Cusick, JF, Morris, GL, Walsh, PR

Volltext

Fulminant progression of demyelinating disease after valproate-induced encephalopathy von BLINDAUER, K. A, HARRINGTON, G, MORRIS, G. L, HO, K.-C

Volltext

Parkinson’s disease disrupts both automatic and controlled processing of action verbs von Fernandino, Leonardo, Conant, Lisa L., Binder, Jeffrey R., Blindauer, Karen, Hiner, Bradley, Spangler, Katie, Desai, Rutvik H.

Volltext

Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study von Mills, Kelly A., Schneider, Ruth B., Saint-Hilaire, Marie, Ross, G. Webster, Hauser, Robert A., Lang, Anthony E., Halverson, Matthew J., Oakes, David, Eberly, Shirley, Litvan, Irene, Blindauer, Karen, Aquino, Camila, Simuni, Tanya, Marras, Connie

Volltext

Where is the action? Action sentence processing in Parkinson's disease von Fernandino, Leonardo, Conant, Lisa L., Binder, Jeffrey R., Blindauer, Karen, Hiner, Bradley, Spangler, Katie, Desai, Rutvik H.

Volltext

Prion infection in cells is abolished by a mutated manganese transporter but shows no relation to zinc von Pass, Rachel, Frudd, Karen, Barnett, James P., Blindauer, Claudia A., Brown, David R.

Volltext

Meta-analysis of Parkinson's Disease: Identification of a novel locus, RIT2 von Pankratz, Nathan, Beecham, Gary W., DeStefano, Anita L., Dawson, Ted M., Doheny, Kimberly F., Factor, Stewart A., Hamza, Taye H., Hung, Albert Y., Hyman, Bradley T., Ivinson, Adrian J., Krainc, Dmitri, Latourelle, Jeanne C., Clark, Lorraine N., Marder, Karen, Martin, Eden R., Mayeux, Richard, Ross, Owen A., Scherzer, Clemens R., Simon, David K., Tanner, Caroline, Vance, Jeffery M., Wszolek, Zbigniew K., Zabetian, Cyrus P., Myers, Richard H., Payami, Haydeh, Scott, William K., Foroud, Tatiana

Volltext

Test-Retest reliability of the Unified Parkinson's Disease Rating Scale in patients with early Parkinson's disease: Results from a multicenter clinical trial von Siderowf, Andrew, McDermott, Michael, Kieburtz, Karl, Blindauer, Karen, Plumb, Sandra, Shoulson, Ira

Volltext

Assessment of capacity to consent in a Huntington disease clinical trial: implications for future clinical trial design in neurodegenerative disease populations (P2.004) von Testa, Claudia, Edmondson, Mary, Agarwal, Pinky, Blindauer, Karen, Gray, Carolyn, Jankovic, Joseph, Kumar, Rajeev, Shprecher, David, Siragusa, Philip, Whaley, Jacquelyn, Frank, Samuel

Volltext

Prion infection in cells is abolished by a mutated manganese transporter but shows no relation to zinc von Pass, Rachel, Frudd, Karen, Barnett, James P., Blindauer, Claudia A., Brown, David R.

Volltext

Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline von deMarcaida, J. Antonelle, Schwid, Steven R., White, William B., Blindauer, Karen, Fahn, Stanley, Kieburtz, Karl, Stern, Matthew, Shoulson, Ira

Volltext

Rasagiline improves quality of life in patients with early Parkinson's disease von Biglan, Kevin M., Schwid, Steven, Eberly, Shirley, Blindauer, Karen, Fahn, Stanley, Goren, Tamar, Kieburtz, Karl, Oakes, David, Plumb, Sandra, Siderowf, Andrew, Stern, Matthew, Shoulson, Ira

Volltext